Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
DFE Pharma, a global leader in pharmaceutical excipient solutions, is excited to announce the launch of a new addition to its broad excipient portfolio, Pharmacel® sMCC 90, a silicified microcrystalline cellulose (MCC).
read more
Recro Pharma Inc, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, announced the signing of a development and ...
read more
MediPharm Labs Corp., a pharmaceutical company specialized in research-driven development and manufacturing of cannabis API and finished products, has received a Drug Establishment Licence (the “DEL”) issued by Health Canada in accordance with the ...
read more
uMotif, experts in patient-centered clinical solutions, announced its collaboration with Xperiome, a global health technology company specializing in rare diseases. The partnership will bring value to both life science companies conducting clinical ...
read more
Aragen Life Sciences (formerly, GVK BIO), a leading Contract Research and Development Organization (CRDO), headquartered out of Hyderabad, India, announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small ...
read more
H.E.L Group (H.E.L), a developer and manufacturer of laboratory tools for process optimization, safety, and scale-up, announced that it has expanded its operations in North America, with the establishment of a West Coast hub in California, and a ...
read more
Thermo Fisher Scientific Inc., has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet the rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines.
read more
Lonza, a CDMO partner to the biopharma industry, announced the extension of its collaboration with a major biopharmaceutical partner for the commercial-scale manufacture of monoclonal antibodies, under a long-term agreement. At scale, and following ...
read more
Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products announced the appointment of Erica Raether as...
read more
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it will commence the first phase of a ...
read more
Element Materials Technology has acquired Arch Sciences Group, a leading provider of analytical services and laboratory solutions in pharmaceuticals. As well as marking Element’s entry into the European pharmaceutical market, the move means that the ...
read more
Catalent announced the launch of a next-generation cell line development technology, GPEx® Lightning. Leveraging Catalent’s proven GPEx expression platform in a glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line system, GPEx ...
read more
SPT Labtech, a laboratory automation solutions company for the life sciences industry, announced that David Newble has been appointed CEO, stepping up from his previous position as Managing Director. In his new capacity, he takes responsibility for ...
read more
Vetter, a leading global Contract Development and Manufacturing?Organization?(CDMO) has further?invested in additional?capacity to meet this growing global demand in Rankweil, Austria. The site has been modified to the high Vetter quality standards ...
read more
Samsung Biologics signed a strategic partnership agreement with Kineta, Inc., a clinical-stage biotech company developing novel immunotherapies in oncology. Samsung Biologics will provide end-to-end CDMO service from cell line development, clinical ...
read more